{"id":"W2036287069","doi":"10.1016/j.ygyno.2013.05.008","title":"Phase II study of temsirolimus (CCI-779) in women with recurrent, unresectable, locally advanced or metastatic carcinoma of the cervix. A trial of the NCIC Clinical Trials Group (NCIC CTG IND 199)","year":2013,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":false,"ca_institutions":"University Health Network; Hamilton Health Sciences; Juravinski Cancer Centre; Queen's University; Cancer Care Ontario; Princess Margaret Cancer Centre; BC Cancer Agency","funders":"BC Cancer Agency","keywords":"Medicine; Temsirolimus; Cervix; Oncology; Internal medicine; Clinical trial; Gynecology; Phases of clinical research; Cancer; Discovery and development of mTOR inhibitors","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007622027,0.001225758,0.00122738,0.0003263555,0.0002458123,0.0005834678,0.0006093892,0.000963327,0.007295526],"category_scores_gemma":[0.000672307,0.0004068239,0.0008918972,0.0002831049,0.0005825437,0.000610254,0.0002629677,0.00219487,0.001213638],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000568684,"about_ca_system_score_gemma":0.001202272,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001329642,"about_ca_topic_score_gemma":0.003856343,"domain_scores_codex":[0.9998313,0.00008111858,0.000006469443,0.00003377406,0.00001343991,0.00003382235],"domain_scores_gemma":[0.9997246,0.0000520692,0.00004985993,0.00001944879,0.00001396623,0.0001401293],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8035793,0.02578337,0.002872826,0.0011808,0.002064476,0.0002426199,0.0002277549,0.002796544,0.02969867,0.0007789913,0.01228463,0.11849],"study_design_scores_gemma":[0.8293995,0.1558974,0.005407909,0.00005168061,0.0005049004,0.0002094425,0.0000708629,0.001163112,0.002010285,0.0003691766,0.004893543,0.00002212347],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.977104,0.006599679,0.0007553566,0.001707425,0.0004359766,0.002743406,0.003438992,0.0001925343,0.00702267],"genre_scores_gemma":[0.9774624,0.004428063,0.001566482,0.002011193,0.0002595906,0.00250827,0.004608492,0.00004034086,0.007115124],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007295526,"threshold_uncertainty_score":0.02440596,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1296047535755556,"score_gpt":0.4369952286122137,"score_spread":0.3073904750366581,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}